Elena Ferri

机构：VIR Biotechnology (United States) · ORCID：0000-0002-8672-4733

发表论文 18 篇 · 总被引 1287 次 · h-index 12

代表论文

• Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution (2022 · Science · 被引 350)
• Bromodomains: Structure, function and pharmacology of inhibition (2015 · Biochemical Pharmacology · 被引 233)
• Predicting the mutational drivers of future SARS-CoV-2 variants of concern (2022 · Science Translational Medicine · 被引 197)
• A pan-influenza antibody inhibiting neuraminidase via receptor mimicry (2023 · Nature · 被引 107)
• Identification of a novel BET bromodomain inhibitor‐sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers (2013 · EMBO Molecular Medicine · 被引 80)
• Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α (2021 · Nature Communications · 被引 78)